financetom
Business
financetom
/
Business
/
Johnson & Johnson discontinues dengue drug study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Johnson & Johnson discontinues dengue drug study
Oct 4, 2024 8:18 AM

Oct 4 (Reuters) - Johnson & Johnson ( JNJ ) said on

Friday it will discontinue its mid-stage field study evaluating

the efficacy of its antiviral drug candidate for the prevention

of dengue.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UAW union files unfair labor practice charges against Volkswagen
UAW union files unfair labor practice charges against Volkswagen
Mar 13, 2025
DETROIT (Reuters) - The United Auto Workers union said Thursday it filed unfair labor practice charges against Volkswagen, saying the automaker is trying to cut jobs at a factory in Tennessee where the union is negotiating its first contract after winning an election there last year. The UAW has notified the Trump Administration of Volkswagen's unacceptable, anti-union, anti-worker, and anti-American...
UAW union files unfair labor practice charges against Volkswagen
UAW union files unfair labor practice charges against Volkswagen
Mar 13, 2025
DETROIT, March 13 (Reuters) - The United Auto Workers union said Thursday it filed unfair labor practice charges against Volkswagen, saying the automaker is trying to cut jobs at a factory in Tennessee where the union is negotiating its first contract after winning an election there last year. The UAW has notified the Trump Administration of Volkswagen's unacceptable, anti-union, anti-worker,...
SoundHound Poised for Growth in 2025 Amid Expanding AI Adoption, Wedbush Says
SoundHound Poised for Growth in 2025 Amid Expanding AI Adoption, Wedbush Says
Mar 13, 2025
11:07 AM EDT, 03/13/2025 (MT Newswires) -- SoundHound AI ( SOUN ) is poised for strong growth in 2025, driven by increasing demand and its ongoing efforts to diversify its AI-powered customer base, despite recent market volatility, Wedbush said in a note Thursday. The company recently filed its Form 10-K after a brief delay due to complexities related to its...
Lendingtree Insider Bought Shares Worth $1,375,429, According to a Recent SEC Filing
Lendingtree Insider Bought Shares Worth $1,375,429, According to a Recent SEC Filing
Mar 13, 2025
11:01 AM EDT, 03/13/2025 (MT Newswires) -- Scott Peyree, Chief Operating Officer, on March 11, 2025, executed a purchase for 32,057 shares in Lendingtree ( TREE ) for $1,375,429. Following the Form 4 filing with the SEC, Peyree has control over a total of 100,772 common shares of the company, with 87,772 shares held directly and 13,000 controlled indirectly. SEC...
Copyright 2023-2025 - www.financetom.com All Rights Reserved